Instituto Ramón y Cajal de Investigación Sanitaria
- A. Health Biotechnology
- Areas of activity
- Medical devices
- Drug development
- Drug discovery
- Gene Therapy
- Therapeutic areas
- Analgesia & Pain
- Musculoskeletal system
- Cardiovascular diseases and circulatory system
- Genetic and rare diseases
- Infectious diseases
- Inflammatory diseases
- Gynaecology and obstetrics
- Ophtalmology and optometry
- Blood and lymphatic system
- Digestive system and hepatology
- Kidney and genitourinary system
- Central nervous system
- Respiratory and pulmonary system
- Metabolic disorders / Endocrinology
- D. Services
- R&D services
The Ramon y Cajal Institute for Biohealth Research (IRYCIS) is a large multidisciplinary organization which integrates scientific and clinical researchers, physicians, and other technical staff from the hospital.
The IRYCIS' aim is to join the knowledge, resources and initiatives of their members, leading to real advances for disease's prevention and treatment, and the improvement of diagnostics technologies.
The research groups of IRYCIS are classified in four major areas:
- Neuroscience and Sense Organs
- Microbiology, Immunology and Infection
- Systemic Patology and Cancer
- Clinical Epidemiology
The Institute led by its Innovation Unit (IU), aims to transfer the research and innovation beyond its walls, and to participate in an european open innovation context contributing to improve patient care and provide new solutions for unmet medical needs.
IRYCIS has a portfolio consisting of patents to out license, services to offer and research projects looking for industrial collaboration. The Institute also wants to open the door to new Horizon 2020 collaborations.